Get started
Author

Irina Odnoletkova

Observed names: I Odnoletkova, I. Odnoletkova, Odnoletkova, I, Odnoletkova, I., Odnoletkova, Irina
ORCID: 0000-0001-5224-1250
Observed ORCID: 0000-0001-5224-1250
OpenAlex ID: A5089107226
The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data
2018 · Irina Odnoletkova, Gerhard Kindle, et al. · Orphanet Journal of Rare Diseases · 196
PDF
Optimizing diabetes control in people with Type 2 diabetes through nurse‐led telecoaching
2016 · I. Odnoletkova, G. Goderis, et al. · Diabetic Medicine · 84
Cost-Effectiveness of Therapeutic Education to Prevent the Development and Progression of Type 2 Diabetes: Systematic Review
2014 · Irina Odnoletkova · Journal of Diabetes & Metabolism · 57
PDF
A guide for the application of analytics on healthcare processes: A dynamic view on patient pathways
2016 · Jasmien Lismont, Anne-Sophie Janssens, et al. · Computers in Biology and Medicine · 40
PDF
Challenges and Opportunities in IBD Clinical Trial Design
2021 · Marla C. Dubinsky, Rory Collins, et al. · Gastroenterology · 36
Delivering Diabetes Education through Nurse-Led Telecoaching. Cost-Effectiveness Analysis
2016 · Irina Odnoletkova, Dirk Ramaekers, et al. · PLoS ONE · 34
PDF
Patient and provider acceptance of telecoaching in type 2 diabetes: a mixed-method study embedded in a randomised clinical trial
2016 · I. Odnoletkova, H. Buysse, et al. · BMC Medical Informatics and Decision Making · 31
PDF
Immunoglobulin Replacement Therapy is critical and cost-effective in increasing life expectancy and quality of life in patients suffering from Common Variable Immunodeficiency Disorders (CVID): A health-economic assessment
2021 · Philippe van Wilder, Irina Odnoletkova, et al. · PLoS ONE · 25
PDF
Nurse-led telecoaching of people with type 2 diabetes in primary care: rationale, design and baseline data of a randomized controlled trial
2014 · Irina Odnoletkova, Geert Goderis, et al. · BMC Family Practice · 22
PDF
Projections of Public Spending on Pharmaceuticals: A Review of Methods
2025 · Irina Odnoletkova, Patrice X. Chalon, et al. · PharmacoEconomics · 5
PDF
Systematic Review on the Cost-Effectiveness of Therapeutic Education to Prevent the Development and Progression of Type 2 Diabetes
2013 · I. Odnoletkova, G. Goderis, et al. · Value in Health · 4
Droit à l’oubli dans le cancer de la thyroïde: recommandations EvidenceBased pour la fixation des délais d’attente - Synthèse
2025 · Irina Odnoletkova, Geert Silversmit, et al. · 3
PDF
Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability
2025 · Ivar Veszelei, Brian Godman, et al. · BioDrugs · 1
PDF
Impact of Nurse-Led Telecoaching on the Annual Healthcare Utilization and Costs in People with Type 2 Diabetes in Belgium. Within-Trial Analysis of Health Insurance Data
2015 · I Odnoletkova, L Annemans, et al. · Value in Health · 1
Health Care Costs in Patients With Type 2 Diabetes in Flanders Based on A Combination of Clinical And Health Insurance Data
2014 · I. Odnoletkova, L. Annemans, et al. · Value in Health · 1
Droit à l’oubli dans le cancer de la thyroïde: recommandations EvidenceBased pour la fixation des délais d’attente - Synthèse
2026 · Irina Odnoletkova, Geert Silversmit, et al.
PDF
Right to be forgotten in thyroid cancer: evidence to inform waiting periods
2026 · Irina Odnoletkova, Geert Silversmit, et al.
PDF
Recht om vergeten te worden bij schildklierkanker: een evidence-based advies voor het bepalen van wachttijden – Synthese
2026 · Irina Odnoletkova, Geert Silversmit, et al.
PDF
OD26 Comparing Health Technology Developers’ Proposed Indication To An Estimated Indication Generated By An International Horizon Scanning Database
2024 · Marie Harte, Caitríona Ní Choitir, et al. · International Journal of Technology Assessment in Health Care
PDF
PP04 Assessing The Utility Of Natural Language Processing In Generating A Granular Estimated Indication For A Horizon Scanning Database
2024 · Caitríona Ní Choitir, Marie Harte, et al. · International Journal of Technology Assessment in Health Care
PDF
Budget impact projections for pharmaceuticals
2024 · Irina Odnoletkova, Dries Reynders, et al.
PDF
Projections de l’impact budgétaire des produits pharmaceutiques
2024 · Irina Odnoletkova, Dries Reynders, et al.
PDF
Budget impact projecties voor geneesmiddelen
2024 · Irina Odnoletkova, Dries Reynders, et al.
PDF
Pcn285 Therapeutic Benefit of Orphan Drugs in Oncology: Evidence at the Point of European Marketing Authorisation
2019 · I. Odnoletkova, Z. Marjenberg, et al. · Value in Health
PDF
Review of National Health Technology Assessment Reports on Treatment of Severe Haemophilia A
2016 · I Odnoletkova · Value in Health
Works count: 35
Citation count: 540
H-index: 9
I10-index: 9
Year
Topic
Type